| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.8M | +146.0% | +471.4% |
| SG&A Expense | $1.5M | +25.7% | +32.5% |
| Operating Income | -$4.3M | -83.5% | -162.2% |
| Pre-tax Income | -$4.2M | — | -165.3% |
| Income Tax | $800 | — | +0.0% |
| Net Income | -$4.2M | -87.7% | -165.2% |
| EPS (Basic) | -$0.49 | -75.0% | -63.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.0M | -17.4% | -28.1% |
| Accounts Receivable | $216K | -49.8% | -43.4% |
| Current Assets | $10.4M | -18.1% | -27.6% |
| Total Assets | $12.4M | -15.8% | -24.7% |
| Current Liabilities | $2.2M | +189.3% | +139.2% |
| Stockholders' Equity | $10.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | -96.6% | — |
| Financing Cash Flow | $3.3M | -0.3% | — |
| -34.4% |